<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="[!info]
üå±‰æÜËá™: [[fecal microbiota transplantation]]
 Recommendations from Professional Organizations of Fecal Microbiota Transplantation  Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) fecal microbiota transplantation (FMT) recommended in adult patients with ‚â• 2 recurrences of Clostridioides (Clostridium) difficile infection (CDI) who have failed appropriate antibiotic treatments consider FMT in pediatric patients with recurrent CDI after standard antibiotic treatments Reference - [Clin Infect Dis 2018 Mar 19;66(7):e1][10][full-text][11], [Clin Infect Dis 2021 Sep 7;73(5):e1029][12]  European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations on use of fecal microbiota transplantation (FMT) in management of Clostridioides difficile infection (CDI) in adults * consider fecal microbiota transplantation (FMT) in patients with severe complicated CDI that have deteriorated despite CDI antibiotic treatment and surgery is not feasible, with decisions made case-by-case by multidisciplinary team ([ESCMID Weak recommendation, Very low-quality evidence][13]) * consider FMT after standard-of-care antibiotic pre-treatment in patients with multiple recurrence( [ESCMID Weak recommendation, Moderate-quality evidence][14]) * adequate multidisciplinary risk assessment needed * FMT products should go through standardized preparation and screening * Reference - [Clin Microbiol Infect 2021 Dec;27 Suppl 2:S1][15]"><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-ph6wrfvo1-htlin222.vercel.app/api/blog?templateTitle=Recommendations from Professional Organizations of Fecal Microbiota Transplantation"><title>Recommendations from Professional Organizations of Fecal Microbiota Transplantation</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.720e2c4835986a3891d6eef3a55faa22.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.3c1b9e9697bb50e1c97a6b814ae7e704.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.ed74564fda89e5b6d43dbf89f0b4c02c.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'‚Äô':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=ÊêúÂ∞ã placeholder="Ë´ãËº∏ÂÖ•ÂÉèÊòØÔºöhypertension ‰πãÈ°ûÁöÑ‰æÜÁúãÊ≤íÊúâÊ≤í‰ªÄÈ∫ºÊúâË∂£ÁöÑüé≥"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>Ëú•Ëú¥Ëä±Âúíü¶éüå±ü™¥üå≤</a></h1><div class=spacer></div><div id=search-icon><p>ÊêúÂ∞ã</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">ÊêúÂ∞ãÂúñÁ§∫</title><desc id="desc">ÊâìÈñãÊêúÂ∞ãÂúñÊ®ô</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>Êòé‰∫ÆÊ®°Âºè</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>ÈªëÊöóÊ®°Âºè</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Recommendations from Professional Organizations of Fecal Microbiota Transplantation</h1><p class=meta>ÊúÄÂæåÊõ¥Êñ∞Êñº
Feb 2, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Recommendations%20from%20Professional%20Organizations%20of%20Fecal%20Microbiota%20Transplantation.md rel=noopener>ü™ö Á∑®ËºØÂéüÂßãÊñá‰ª∂</a></p><ul class=tags></ul><blockquote class=info-callout><p></p><p>üå±‰æÜËá™: <a href=/fecal-microbiota-transplantation rel=noopener class=internal-link data-src=/fecal-microbiota-transplantation>fecal microbiota transplantation</a></p></blockquote><a href=#recommendations-from-professional-organizations-of-fecal-microbiota-transplantation><h1 id=recommendations-from-professional-organizations-of-fecal-microbiota-transplantation><span class=hanchor arialabel=Anchor># </span>Recommendations from Professional Organizations of Fecal Microbiota Transplantation</h1></a><ul><li>Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA)</li><li>fecal microbiota transplantation (FMT) recommended in adult patients with ‚â• 2 recurrences of <em>Clostridioides (Clostridium) difficile</em> infection (CDI) who have failed appropriate antibiotic treatments</li><li>consider FMT in pediatric patients with recurrent CDI after standard antibiotic treatments</li><li>Reference - [Clin Infect Dis 2018 Mar 19;66(7):e1][10][full-text][11], [Clin Infect Dis 2021 Sep 7;73(5):e1029][12]</li></ul><p>European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations on use of fecal microbiota transplantation (FMT) in management of <em>Clostridioides difficile</em> infection (CDI) in adults
* consider fecal microbiota transplantation (FMT) in patients with severe complicated CDI that have deteriorated despite CDI antibiotic treatment and surgery is not feasible, with decisions made case-by-case by multidisciplinary team ([ESCMID Weak recommendation, Very low-quality evidence][13])
* consider FMT after standard-of-care antibiotic pre-treatment in patients with multiple recurrence( [ESCMID Weak recommendation, Moderate-quality evidence][14])
* adequate multidisciplinary risk assessment needed
* FMT products should go through standardized preparation and screening
* Reference - [Clin Microbiol Infect 2021 Dec;27 Suppl 2:S1][15]</p><ul><li>British Society of Gastroenterology/Healthcare Infection Society (BSG/HIS) recommendations on FMT for <em>C. difficile</em> infection<ul><li>recipient selection<ul><li>CDI history<ul><li>offer FMT to patients with recurrent CDI, including ([BSG/HIS Strong recommendation, High-quality evidence][16])<ul><li>patients with ‚â• 2 recurrences of <em>C. difficile</em> infection OR</li><li>patients with 1 recurrence and risk factors for further recurrences, such as severe/complicated CDI</li></ul></li><li>strongly consider FMT in patients with refractory CDI ([BSG/HIS Strong recommendation, Moderate-quality evidence][17])</li></ul></li><li>treatment history<ul><li>do not offer FMT as initial therapy for CDI ([BSG/HIS Strong recommendation, Low-quality evidence][18])</li><li>consider FMT for recurrent CDI only after ([BSG/HIS Strong recommendation, Low-quality evidence][19])<ul><li>symptom recurrence after resolution of an episode of CDI treated with ‚â• 10 days of appropriate antimicrobial therapy</li><li>consideration of treatment with extended/pulsed vancomycin and/or fidaxomicin</li><li>consideration of treatment with medications associated with reduced risk of recurrence (such as, fidaxomicin and bezlotoxumab) in patients with severe or complicated CDI</li></ul></li></ul></li><li>comorbidities and immunosuppression<ul><li>avoid FMT in patients with history of anaphylactic food allergy ([BSG/HIS Strong recommendation, Very low-quality evidence][20])</li><li>consider FMT with caution in patients with CDI and decompensated chronic liver disease ([BSG/HIS Weak recommendation, Very low-quality evidence][21])</li><li>offer FMT to patients with recurrent CDI and inflammatory bowel disease (IBD) with counselling on risks of IBD exacerbation ([BSG/HIS Strong recommendation, Moderate-quality evidence][22])</li><li>in patients with immunosuppression or immunocompromise<ul><li>offer FMT with caution ([BSG/HIS Strong recommendation, Moderate-quality evidence][23])</li><li>for immunocompromised recipients at risk of severe infection if exposed to cytomegalovirus or Epstein-Barr virus, choose donor negative for these viruses ([BSG/HIS Strong recommendation, Very low-quality evidence][24])</li></ul></li><li>offer FMT to appropriate patients with recurrent CDI regardless of other comorbidities ([BSG/HIS Strong recommendation, Moderate-quality evidence][25])</li></ul></li></ul></li><li>give further antimicrobial treatment for CDI for ‚â• 72 hours prior to FMT ([BSG/HIS Strong recommendation, Low-quality evidence][26])</li><li>use of banked, frozen FMT is preferred over fresh preparations for treatment of recurrent CDI infection ([BSG/HIS Strong recommendation, High-quality evidence][27])<ul><li>frozen FMT material has a maximum shelf life of 6 months from preparation when stored at -80 degrees C (-112 degrees F) (recommended) ([BSG/HIS Strong recommendation, Low-quality evidence][28])</li><li>consider thawing frozen samples at ambient temperature and use within 6 hours of thawing ([BSG/HIS Weak recommendation, Low-quality evidence][29])</li><li>avoid thawing frozen samples in warm water baths due to risks of cross-contamination and reduced bacterial viability ([BSG/HIS Weak recommendation, Very low-quality evidence][30])</li></ul></li><li>follow best practices for prevention of further transmission of CDI during administration of FMT, including enteric precautions and sporicidal treatment of endoscope and other instruments ([BSG/HIS Strong recommendation, High-quality evidence][31])</li><li>cure and treatment failure definitions<ul><li>record decision regarding cure/remission during follow-up, however, there is no universal definition and clinicians should decide on a case-by-case basis ([BSG/HIS Strong recommendation, Very low-quality evidence][32])</li><li>define treatment failure/recurrence on a case-by-case basis and routine testing for <em>C. difficile</em> toxin after FMT is not recommended, but may be considered in patients with persistent symptoms or suspected relapse ([BSG/HIS Strong recommendation, Low-quality evidence][33])</li></ul></li><li>Reference - BSG/HIS guideline on use of fecal microbiota transplant as treatment for recurrent or refractory <em>C. difficile</em> infection ([Gut 2018 Nov;67(11):1920][34][PDF][35])</li></ul></li></ul><hr><h2 id=enabletoc-false>title:Recommendations from Professional Organizations of Fecal Microbiota Transplantation
date: &ldquo;2023-02-02&rdquo;
enableToc: false</h2><blockquote class=info-callout><p></p><p>üå±‰æÜËá™: <a href=/fecal-microbiota-transplantation rel=noopener class=internal-link data-src=/fecal-microbiota-transplantation>fecal microbiota transplantation</a></p></blockquote><a href=#recommendations-from-professional-organizations-of-fecal-microbiota-transplantation-1><h1 id=recommendations-from-professional-organizations-of-fecal-microbiota-transplantation-1><span class=hanchor arialabel=Anchor># </span>Recommendations from Professional Organizations of Fecal Microbiota Transplantation</h1></a><ul><li><p>Infectious Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA)</p><ul><li>fecal microbiota transplantation (FMT) recommended in adult patients with ‚â• 2 recurrences of <em>Clostridioides (Clostridium) difficile</em> infection (CDI) who have failed appropriate antibiotic treatments ([IDSA/SHEA Strong recommendation, Moderate-quality evidence][8])</li><li>consider FMT in pediatric patients with recurrent CDI after standard antibiotic treatments ([IDSA/SHEA Weak recommendation, Very low-quality evidence][9])</li><li>Reference - [Clin Infect Dis 2018 Mar 19;66(7):e1][10][full-text][11], [Clin Infect Dis 2021 Sep 7;73(5):e1029][12]</li></ul></li><li><p>Evidence Updated 29 Nov 2022</p><p>European Society of Clinical Microbiology and Infectious Diseases (ESCMID) recommendations on use of fecal microbiota transplantation (FMT) in management of <em>Clostridioides difficile</em> infection (CDI) in adults</p><ul><li>consider fecal microbiota transplantation (FMT) in patients with severe complicated CDI that have deteriorated despite CDI antibiotic treatment and surgery is not feasible, with decisions made case-by-case by multidisciplinary team ([ESCMID Weak recommendation, Very low-quality evidence][13])</li><li>consider FMT after standard-of-care antibiotic pre-treatment in patients with multiple recurrence( [ESCMID Weak recommendation, Moderate-quality evidence][14])<ul><li>adequate multidisciplinary risk assessment needed</li><li>FMT products should go through standardized preparation and screening</li></ul></li><li>Reference - [Clin Microbiol Infect 2021 Dec;27 Suppl 2:S1][15]</li></ul></li><li><p>British Society of Gastroenterology/Healthcare Infection Society (BSG/HIS) recommendations on FMT for <em>C. difficile</em> infection</p><ul><li>recipient selection<ul><li>CDI history<ul><li>offer FMT to patients with recurrent CDI, including ([BSG/HIS Strong recommendation, High-quality evidence][16])<ul><li>patients with ‚â• 2 recurrences of <em>C. difficile</em> infection OR</li><li>patients with 1 recurrence and risk factors for further recurrences, such as severe/complicated CDI</li></ul></li><li>strongly consider FMT in patients with refractory CDI ([BSG/HIS Strong recommendation, Moderate-quality evidence][17])</li></ul></li><li>treatment history<ul><li>do not offer FMT as initial therapy for CDI ([BSG/HIS Strong recommendation, Low-quality evidence][18])</li><li>consider FMT for recurrent CDI only after ([BSG/HIS Strong recommendation, Low-quality evidence][19])<ul><li>symptom recurrence after resolution of an episode of CDI treated with ‚â• 10 days of appropriate antimicrobial therapy</li><li>consideration of treatment with extended/pulsed vancomycin and/or fidaxomicin</li><li>consideration of treatment with medications associated with reduced risk of recurrence (such as, fidaxomicin and bezlotoxumab) in patients with severe or complicated CDI</li></ul></li></ul></li><li>comorbidities and immunosuppression<ul><li>avoid FMT in patients with history of anaphylactic food allergy ([BSG/HIS Strong recommendation, Very low-quality evidence][20])</li><li>consider FMT with caution in patients with CDI and decompensated chronic liver disease ([BSG/HIS Weak recommendation, Very low-quality evidence][21])</li><li>offer FMT to patients with recurrent CDI and inflammatory bowel disease (IBD) with counselling on risks of IBD exacerbation ([BSG/HIS Strong recommendation, Moderate-quality evidence][22])</li><li>in patients with immunosuppression or immunocompromise<ul><li>offer FMT with caution ([BSG/HIS Strong recommendation, Moderate-quality evidence][23])</li><li>for immunocompromised recipients at risk of severe infection if exposed to cytomegalovirus or Epstein-Barr virus, choose donor negative for these viruses ([BSG/HIS Strong recommendation, Very low-quality evidence][24])</li></ul></li><li>offer FMT to appropriate patients with recurrent CDI regardless of other comorbidities ([BSG/HIS Strong recommendation, Moderate-quality evidence][25])</li></ul></li></ul></li><li>give further antimicrobial treatment for CDI for ‚â• 72 hours prior to FMT ([BSG/HIS Strong recommendation, Low-quality evidence][26])</li><li>use of banked, frozen FMT is preferred over fresh preparations for treatment of recurrent CDI infection ([BSG/HIS Strong recommendation, High-quality evidence][27])<ul><li>frozen FMT material has a maximum shelf life of 6 months from preparation when stored at -80 degrees C (-112 degrees F) (recommended) ([BSG/HIS Strong recommendation, Low-quality evidence][28])</li><li>consider thawing frozen samples at ambient temperature and use within 6 hours of thawing ([BSG/HIS Weak recommendation, Low-quality evidence][29])</li><li>avoid thawing frozen samples in warm water baths due to risks of cross-contamination and reduced bacterial viability ([BSG/HIS Weak recommendation, Very low-quality evidence][30])</li></ul></li><li>follow best practices for prevention of further transmission of CDI during administration of FMT, including enteric precautions and sporicidal treatment of endoscope and other instruments ([BSG/HIS Strong recommendation, High-quality evidence][31])</li><li>cure and treatment failure definitions<ul><li>record decision regarding cure/remission during follow-up, however, there is no universal definition and clinicians should decide on a case-by-case basis ([BSG/HIS Strong recommendation, Very low-quality evidence][32])</li><li>define treatment failure/recurrence on a case-by-case basis and routine testing for <em>C. difficile</em> toxin after FMT is not recommended, but may be considered in patients with persistent symptoms or suspected relapse ([BSG/HIS Strong recommendation, Low-quality evidence][33])</li></ul></li><li>Reference - BSG/HIS guideline on use of fecal microbiota transplant as treatment for recurrent or refractory <em>C. difficile</em> infection ([Gut 2018 Nov;67(11):1920][34][PDF][35])</li></ul></li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>‚Ü©Ô∏è ÂèçÂêëÈÄ£Áµê</h3><ul class=backlinks><li><a href=/fecal-microbiota-transplantation/ data-ctx="Recommendations from Professional Organizations of Fecal Microbiota Transplantation" data-src=/fecal-microbiota-transplantation class=internal-link>Fecal Microbiota Transplantation</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>ü§Ø‰∫íÂãïÂúñ</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>Êú¨Á∂≤Á´ôÊòØÁî± Hsieh-Ting Lin ‰ª•‚ù§Ô∏è Áî® <a href=https://github.com/jackyzha0/quartz>Quartz</a>ÈÄôÂÄãÈÖ∑Êù±Ë•øÁ®ÆÂá∫‰æÜü™¥ , ¬© 2023</p><ul><li><a href=https://www.physician.tw/>üè†È¶ñÈ†Å</a></li><li><a href=https://www.facebook.com/Tim.H.Lin>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://medium.com/@hsieh-ting-lin>Medium</a></li></ul></footer></div></div></body></html>